BEIJING, China, September 11, 2026 — GL Capital, a leading China-focused professional healthcare investment firm, today announced that it has brought Novo Holdings, a leading global healthcare and life sciences investment firm, in as a minority strategic investor in its portfolio company Huizhou ForYou Medical Co., Ltd. ("ForYou Medical"). The transaction marks a major milestone in the GL Capital-led capital structure upgrade and global expansion of ForYou Medical. Novo Holdings will take a minority equity stake, while GL Capital continues as the controlling shareholder, working alongside management to drive long-term value creation.

Headquartered in Huizhou, Guangdong Province, ForYou Medical is a contract development and manufacturing organization (CDMO) focused on advanced wound care technologies and products. Since its founding in 2005, the company has built innovation into its core operating DNA, integrating polymer and biomaterial research, product development, regulatory affairs and large-scale manufacturing into a single, vertically integrated platform. Leveraging its strong R&D capabilities, deep regulatory expertise and proven manufacturing capacity, ForYou Medical supports customers across the full innovation lifecycle — from concept development and product registration to commercial-scale production. Today, its advanced wound care portfolio serves leading healthcare companies across Europe, North America and Asia.

GL Capital became the controlling shareholder of ForYou Medical in 2023. Leveraging its seasoned post-investment team and deep industry expertise, the firm has provided multi-dimensional value-add across strategic planning, domestic and overseas market development, and brand building. Over the past three years, GL Capital has helped ForYou Medical strengthen its R&D and manufacturing foundation, expand its international customer network and adopt global-standard management systems — laying the groundwork for today's introduction of a top-tier global strategic investor.

Advanced wound care is a structurally growing segment, powered by an aging population, rising prevalence of chronic wounds and the broader adoption of advanced therapies. At the same time, more healthcare companies are partnering with specialist manufacturers to accelerate innovation, broaden their product pipelines and improve operational efficiency, fueling sustained demand for high-quality CDMO partners. Against this backdrop, GL Capital's decision to bring in Novo Holdings reflects the latter's global network in life sciences, long-term value investment philosophy and continued confidence in China's healthcare innovation ecosystem.

Mr. Zhenfu Li, Chief Executive Officer of GL Capital, commented:

"Since our investment in ForYou Medical, we have been working closely with the management team to continuously strengthen the company's overall capabilities and accelerate its business growth. We are very pleased to welcome Novo Holdings as a like-minded long-term investor. Its deep global healthcare industry experience and international network will further empower ForYou Medical's next stage of development."

Amit Kakar, Managing Partner and Head of Asia at Novo Holdings, commented:

"China is continuing to consolidate its position as a global hub for medical innovation and high-end advanced manufacturing. Novo Holdings is committed to partnering with high-quality companies with strong technological capabilities, international competitiveness, and long-term growth potential. ForYou Medical is a typical example of such a company, and this investment also confirms our confidence in the continued development of China's life sciences ecosystem."

Mr. Jinwen Mo, Chief Executive Officer of ForYou Medical, commented:

"We are honored to introduce Novo Holdings as a strategic investor. Its deep global healthcare industry ecosystem, long-term value investment philosophy, and international resource network make it an ideal partner for us to strengthen our innovation capabilities and serve our global customers. We will continue to work hand-in-hand with GL Capital, build on our solid foundation, and create long-term value for our customers, employees, and partners."

About GL Capital

GL Capital is a China-focused investment firm specializing in control investments and growth-stage opportunities in the healthcare sector. Founded in 2010 by Mr. Zhenfu Li, former President of Novartis China, the firm manages USD- and RMB-denominated private equity, venture capital and hedge fund vehicles, with assets under management (AUM) exceeding RMB 30 billion.

GL Capital is committed to being the most trusted partner to industry leaders and to delivering superior returns to its investors, while contributing to the healthy development of China's healthcare sector. As the world's second-largest healthcare market, China presents abundant investment opportunities driven by structural reform, an aging population and improving medical infrastructure. GL Capital focuses on outstanding companies with sustainable competitive advantages, partnering with like-minded, visionary management teams to pursue excellence and create long-term value.

About Novo Holdings

Novo Holdings is a holding and investment company responsible for managing the assets of the Novo Nordisk Foundation. Its core mission is to generate attractive long-term returns on the Foundation's assets to support scientific, humanitarian and social causes that improve people's health and contribute to the sustainability of society and the planet. In addition to allocations across equities, fixed income, real estate, infrastructure and private equity, Novo Holdings is also a leading global investor in life sciences. As of year-end 2025, Novo Holdings had total assets under management of EUR 93 billion.

https://novoholdings.dk/

About ForYou Medical

ForYou Medical, founded in 2005 and headquartered in Huizhou, Guangdong Province, China, is a contract development and manufacturing organization (CDMO) focused on advanced wound care products. The company develops and manufactures a diversified portfolio including advanced wound dressings, hemostatic products and bioabsorbable materials, serving healthcare companies across major global markets. ForYou Medical combines advanced manufacturing capabilities with deep regulatory expertise, anchored in a steadfast commitment to product innovation and quality control.

https://en.foryoumedical.com/

Media Contact

GL Capital — Media Relations media@gl-capital.com